Case File
efta-01831563DOJ Data Set 10OtherEFTA01831563
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01831563
Pages
5
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Paul S Barre
From:
Jeffrey Epstein
Sent
Thur 12/9/2010 4:31:29 PM
Subject Re: Oil should i have watched mysefill this is ridiculous
On Thu, Dec 9, 2010 at 11:30 AM, Paul S Barrett wrote:
$30,000 — $119,000
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
3PMorgan Private Bank
40W 57th Street, 33rd Floor, New York, NY 10019
212-622-2770 (W)
212-310-0108 (F)
From: Jeffrey Epstein [mailto:imacationlitemail,com1
Sent: Thursday, December 09, 2010 11:27 AM
To: Paul S Barrett
Subject: Re: Oil no the range of the calls
On Thu, Dec 9, 2010 at 11:25 AM, Paul S Barrett
90.85 on the 7th of Dec
Range has been 80 - 90.85 over the past 30days wrote:
EFTA_R1_00208648
EFTA01831563
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
40W 57th Street, 33rd Floor, New York, NY 10019
212-622-2770 (W)
212-310-0108 (F)
From: Jeffrey Epstein [mailto:jeevaeationTsmil.coal
Sent: Thursday, December 09, 2010 11:23 AM
To: Paul S Barrett
Subject: Re: Oil how high did it get in the past two weeks„
On Thu, Dec 9, 2010 at 11:06 AM, Paul S Barrett <g vrote:
We can sell the 90 oil call that expires next week for 30,000. Was cashless upfront.
Ncw risk reversal would be:
Aug2011 contract
100 Call
81.25 Put
Or
105 Call
EFTA_R1_00208649
EFTA01831564
77.25 Put
Both cashless
I like the l" strategy
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
IPMorgan Private Bank
40W S7th Street, 33rd Floor, New York, NY 10019
This email is confidential and subject to important disclaimers and conditions including on offers
for the purchase or sale of securities, accuracy and completeness of information, viruses,
confidentiality, legal privilege, and legal entity disclaimers, available at
hup://www.ipmorgan.com/pages/disclosurcsiemail.
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
EFTA_R1_00208650
EFTA01831565
communication or any part thereof is strictly prohibited and may be unlawful. if you have received this
communication in error, please notify us immediately by return e-mail or by e-mail to jcc‘[email protected], and
destroy this communication and all copies thereof, including all attachments.
This email is confidential and subject to important disclaimers and conditions including on offers
for the purchase or sale of securities, accuracy and completeness of information, viruses,
confidentiality, legal privilege, and legal entity disclaimers, available at
http://www.ipmorgan.cominages/diselosureskmail.
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof,
including all attachments.
This email is confidential and subject to important disclaimers and conditions including on offers
for the purchase or sale of securities, accuracy and completeness of information, viruses,
confidentiality, legal privilege, and legal entity disclaimers, available at
http://www.ipmorgan.com/pages/disclosures/email.
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this communication in error, please notify us immediately by
EFTA_R1_00208651
EFTA01831566
return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof,
including all attachments.
EFTA_R1_00208652
EFTA01831567
Technical Artifacts (6)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Phone
212-310-0108Phone
212-622-2770URL
http://www.ipmorgan.com/pages/disclosures/emailURL
http://www.ipmorgan.cominages/diselosureskmailRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.